1722
L. Pei, W. Qian
LETTER
P.; Wife, R. Tetrahedron Lett. 2002, 43, 2539. (k) Hamada,
T.; Chieffi, A.; Åhman, J.; Buchwald, S. L. J. Am. Chem.
Soc. 2002, 124, 1261. (l) Viciu, M. S.; Germaneau, R. F.;
Nolan, S. P. Org. Lett. 2002, 4, 4053.
16.4 Hz, CH), 7.34–7.43 (5 H, m, ArH) 16.75 (1 H, s, OH).
13C NMR (100 MHz, CDCl3): d = 24.23, 111.30, 122.73,
126.05, 127.65, 128.66, 134.16, 137.02, 191.16. MS (70
eV): m/z (%) = 209.0992 (43), 176.0828 (100). HRMS (70
eV): m/z calcd for C13H14O2, 202.0988; found: 202.0992.
(E)-Ethyl-2-acetyl-4-phenylbut-3-enoate (Table 2, entry
2): IR (film): 3459.6, 3061.9, 3029.3, 2982.8, 2936.7,
1732.5, 1599.7, 1449.9, 1368.5, 1247.5, 1079.8, 1018.0,
757.9, 699.6 cm–1. 1H NMR (400 MHz, CDCl3): d = 1.29
(1.2 H, t, J = 7.2 Hz, CH3), 1.35 (1.8 H, t, J = 7.2 Hz, CH3),
2.22 (1.8 H, s, CH3), 2.28 (1.2 H, s, CH3), 4.23 (0.8 H, q, J =
7.2 Hz, CH2), 4.24 (0.4 H, s, CH), 4.30 (1.2 H, q, J = 7.2 Hz,
CH2), 6.42 (0.4 H, dd, J = 16.0, 9.2 Hz, CH), 6.58 (0.4 H, d,
J = 16.0 Hz, CH), 6.60 (0.6 H, d, J = 16.0 Hz, CH), 6.74 (0.6
H, d, J = 16.0 Hz, CH), 7.31–7.42 (5 H, m, ArH), 13.37 (0.6
H, s, OH). 13C NMR (100 MHz, CDCl3): d = 14.03, 14.19,
20.28, 28.45, 60.92, 61.68, 63.87, 101.28, 120.99, 121.57,
125.91, 126.56, 127.04, 128.18, 128.54, 128.60, 130.62,
135.36, 135.99, 138.03, 168.41, 172.63, 174.64, 201.38. MS
(70 eV): m/z (%) = 232.1099 (84) [M+], 205.0856 (100),
190.0986 (97), 171.0440 (62). HRMS (70 eV): m/z calcd for
C14H16O3: 232.1094; found: 232.1099.
(3) (a) Hassan, J.; Sévignon, M.; Gozzi, C.; Schulz, E.; Lemaire,
M. Chem. Rev. 2002, 102, 1359. (b) Ley, S. V.; Thomas, A.
W. Angew. Chem. Int. Ed. 2003, 42, 5400. (c) Kunz, K.;
Scholz, U.; Ganzer, D. Synlett 2003, 2428. (d) Hennessy, E.
J.; Buchwald, S. L. Org. Lett. 2002, 4, 269. (e) Ma, D.; Liu,
F. Chem. Commun. 2004, 1934. (f) Zhang, S.; Zhang, D.;
Liebeskind, L. S. J. Org. Chem. 1997, 62, 2312. (g) Bates,
C. G.; Saejueng, P.; Venkataraman, D. Org. Lett. 2004, 6,
1441. (h) Jiang, Y.; Wu, N.; Wu, H.; He, M. Synlett 2005,
2731.
(4) (a) Hurtley, W. R. H. J. Chem. Soc. 1929, 1870.
(b) Bruggink, A.; Ray, S. J.; McKillop, A. Org. Synth. 1978,
58, 52. (c) Bryson, T. A.; Stewart, J. J.; Gibson, J. M.;
Thomas, P. S.; Berch, J. K. Green Chem. 2003, 5, 174.
(d) Bruggink, A.; McKillop, A. Tetrahedron 1975, 31,
2607. (e) Lindley, J. Tetrahedron 1984, 40, 1433.
(f) Shinkwin, A. E.; Whish, W. J. D.; Threadgill, M. D.
Bioorg. Med. Chem. 1999, 7, 297.
(5) (a) Hang, H. C.; Drotleff, E.; Elliott, G. I.; Ritsema, T. A.;
Konopelski, J. P. Synthesis 1999, 398. (b) Suzuki, H.; Yi,
Q.; Inoue, J.; Kusume, K.; Ogawa, T. Chem. Lett. 1987,
887. (c) Suzuki, H.; Kobayashi, T.; Osuka, A. Chem. Lett.
1983, 589.
(E)-Diethyl-2-styrylmalonate (Table 2, entry 3): IR (film):
2983.3, 2938.7, 2909.6, 1732.6, 1465.2, 1449.4, 1369.3,
1258.4, 1151.3, 1033.8, 967.1, 857.8, 757.9, 692.7 cm–1. 1H
NMR (400 MHz, CDCl3): d = 1.28 (6 H, t, J = 7.2 Hz, CH3),
4.17–4.26 (5 H, m, CH2, CH), 6.42 (1 H, dd, J = 16.0, 8.8
Hz, CH), 6.59 (1 H, d, J = 16.0 Hz, CH), 7.27–7.42 (5 H, m,
ArH). 13C NMR (100 MHz, CDCl3): d = 13.96, 55.86,
61.40, 120.84, 126.56, 128.01, 128.49, 134.96, 136.04,
167.96. MS (70 eV): m/z (%) = 262.1204 (100) [M+],
190.0989 (53), 189.0911 (28). HRMS (70 eV): m/z calcd for
C15H18O4: 262.1200; found: 262.1204.
(E)-3-(4-Chlorostyryl)pentane-2,4-dione (Table 2, entry
5): IR (film): 3055.4, 2913.6, 1443.6, 1071.7, 748.8, 692.1
cm–1. 1H NMR (400 MHz, CDCl3): d = 2.22 (6 H, s, CH3),
6.36 (1 H, d, J = 16.4 Hz, CH), 6.72 (1 H, d, J = 16.4 Hz,
CH), 7.30–7.36 (4 H, m, ArH) 16.78 (1 H, s, OH). 13C NMR
(100 MHz, CDCl3): d = 24.27, 111.12, 123.38, 127.23,
128.78, 132.74, 133.22, 135.51, 191.20. MS: m/z (%) =
236.0601 (100) [M+], 238.0575 (35) [M+ + 2], 221.0365
(30). HRMS (70 eV): m/z calcd for C13H13ClO2: 236.0599;
found: 236.0601.
(E)-Ethyl-2-acetyl-4-(4-chlorophenyl)but-3-enoate
(Table 2, entry 6): IR (film): 3471.5, 2982.2, 2929.3, 1722.1,
1592.1, 1491.8, 1368.8, 1247.0, 1092.0, 1013.7, 974.4,
828.9 cm–1. 1H NMR (400 MHz, CDCl3): d = 1.30 (1.2 H, t,
J = 7.2 Hz, CH3), 1.36 (1.8 H, t, J = 7.2 Hz, CH3), 2.22 (1.8
H, s, CH3), 2.29 (1.2 H, s, CH3), 4.24 (0.8 H, q, J = 7.2 Hz,
CH2), 4.25 (0.4 H, s, CH), 4.30 (1.2 H, q, J = 7.2 Hz, CH2),
6.40 (0.4 H, dd, J = 16.0, 8.8 Hz, CH), 6.52 (0.4 H, d, J =
16.0 Hz, CH), 6.56 (0.6 H, d, J = 16.0 Hz, CH), 6.71 (0.6 H,
d, J = 16.0 Hz, CH), 7.27–7.34 (4 H, m, ArH), 13.41 (0.6 H,
s, OH). 13C NMR (100 MHz, CDCl3): d = 14.04, 14.22,
20.32, 28.56, 61.02, 61.81, 63.72, 76.61, 101.10, 121.67,
122.15, 127.06, 127.77, 128.66, 128.79, 129.09, 132.50,
134.07, 134.48, 136.58, 168.27, 172.53, 175.02, 201.13. MS
(70 eV): m/z (%) = 216.1146 (100) [M+], 268.0679 (38)
[M+ + 2], 240.0554 (40), 224.0598 (80), 220.0288 (74),
207.0022 (42), 205.0052 (98). HRMS (70 eV): m/z calcd for
C14H15ClO3: 266.0704; found: 216.1146.
(6) Okuro, K.; Furuune, M.; Miura, M.; Nomura, M. J. Org.
Chem. 1993, 58, 7606.
(7) (a) Ma, D.; Cai, Q.; Xie, X. Synlett 2005, 1767. (b) Zhu,
W.; Ma, D. J. Org. Chem. 2005, 70, 2696. (c) Cai, Q.; Zhu,
W.; Zhang, H.; Zhang, Y.; Ma, D. Synthesis 2005, 496.
(d) Ma, D.; Cai, Q.; Zhang, H. Org. Lett. 2003, 5, 2453.
(e) Ma, D.; Cai, Q. Org. Lett. 2003, 5, 3799. (f) Ma, D.;
Cai, Q. Synlett 2004, 128. (g) Pan, X.; Cai, Q.; Ma, D. Org.
Lett. 2004, 6, 1809. (h) Zhu, W.; Ma, D. Chem. Commun.
2004, 888. (i) Zhang, H.; Cai, Q.; Ma, D. J. Org. Chem.
2005, 70, 5164. (j) Xie, X.; Cai, G.; Ma, D. Org. Lett. 2005,
7, 4693.
(8) (a) Marcoux, J.-F.; Doye, S.; Buchwald, S. L. J. Am. Chem.
Soc. 1997, 119, 10539. (b) Kiyomori, A.; Marcoux, J. F.;
Buchwald, S. L. Tetrahedron Lett. 1999, 40, 2657.
(c) Wolter, M.; Klapars, A.; Buchwald, S. L. Org. Lett. 2001,
3, 3803. (d) Klapars, A.; Antilla, J. C.; Huang, X.;
Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 7727.
(e) Antilla, J. C.; Buchwald, S. L. Org. Lett. 2001, 3, 2077.
(9) Wang, Z.; Bao, W.; Jiang, Y. Chem. Commun. 2005, 2849.
(10) (a) Wan, Z.; Jones, C. D.; Koenig, T. M.; Pu, Y. J.; Mitchell,
D. Tetrahedron Lett. 2003, 44, 8257. (b) Willis, M. C.;
Taylor, D.; Gillmore, A. T. Chem. Commun. 2003, 2222.
(c) Nordmann, G.; Buchwald, S. L. J. Am. Chem. Soc. 2003,
125, 4978.
(11) Typical Procedure: A two-necked flask was charged with
vinyl bromide (0.5 mmol), CuI (0.05 mmol), L-proline (0.1
mmol), and Cs2CO3 (1.0 mmol), evacuated, and backfilled
with nitrogen. The activated methylene compound (1.0
mmol) and DMSO (2 g) were added under nitrogen. The
flask was immersed in a pre-heated oil bath, and the reaction
mixture was stirred at 90 °C until the conversion was
complete (detected by TLC). The cooled mixture was
purified by column chromatography on silica gel (PE–
EtOAc, 10:1 to 5:1) to provide the desired product.
(E)-3-Styrylpentane-2,4-dione (Table 2, entry 1): IR
(film): 3429.1, 3062.4, 3029.7, 2927.2, 1709.1, 1600.9,
1495.2, 1450.2, 1357.4, 1204.9, 1143.7, 1025.8, 976.2,
751.0, 699.4 cm–1. 1H NMR (400 MHz, CDCl3): d = 2.21 (6
H, s, CH3), 6.41 (1 H, d, J = 16.4 Hz, CH), 6.74 (1 H, d, J =
(E)-Diethyl-2-(4-chlorostyryl)malonate (Table 2, entry 7):
IR (film): 2983.7, 2934.6, 1732.7, 1492.2, 1465.7, 1446.6,
1369.5, 1256.7, 1151.2, 1094.7, 1035.1, 968.7, 821.9 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.29 (6 H, t, J = 7.2 Hz,
CH3), 4.16–4.26 (5 H, m, CH2, CH), 6.40 (1 H, dd, J = 16.0,
8.8 Hz, CH), 6.55 (1 H, d, J = 16.0 Hz, CH), 7.28–7.35 (4 H,
Synlett 2006, No. 11, 1719–1723 © Thieme Stuttgart · New York